MoneyWorks4Me

Beryl Drugs - Quaterly Results

09 Aug 2022 Evaluate
The Revenue for the quarter ended  June 2022 of Rs. 49.68 millions grew by 6.88 % from Rs. 46.48 millions.Net Profit of the company move down -35.99% to Rs. 2.17  millions from Rs. 3.39 millions  in the same quarter last year.Operating profit for the quarter ended June 2022 decreased to 5.94 millions as compared to 7.08 millions of corresponding quarter ended June 2021.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202206 202106 % Var 202206 202106 % Var 202203 202103 % Var
Sales 49.68 46.48 6.88 49.68 46.48 6.88 147.69 142.80 3.42
Other Income 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBIDT 5.94 7.08 -16.10 5.94 7.08 -16.10 5.73 16.36 -64.98
Interest 1.26 1.11 13.51 1.26 1.11 13.51 4.37 4.66 -6.22
PBDT 4.68 5.97 -21.61 4.68 5.97 -21.61 1.36 16.22 -91.62
Depreciation 2.47 2.99 -17.39 2.47 2.99 -17.39 10.86 12.73 -14.69
PBT 2.21 2.98 -25.84 2.21 2.98 -25.84 -9.50 3.49 -372.21
TAX 0.04 -0.41 -109.76 0.04 -0.41 -109.76 -2.91 1.08 -369.44
Deferred Tax 0.04 -0.41 -109.76 0.04 -0.41 -109.76 -3.00 1.08 -377.78
PAT 2.17 3.39 -35.99 2.17 3.39 -35.99 -6.59 2.41 -373.44
Equity 50.72 50.72 0.00 50.72 50.72 0.00 50.72 50.72 0.00
PBIDTM(%) 11.96 15.23 -21.51 11.96 15.23 -21.51 3.88 11.46 -66.13
Peers
Company Name CMP
Sun Pharma. Inds. 1847.00
Dr. Reddys Labs. 1212.30
Cipla 1368.65
Lupin 2121.05
Zydus Lifesciences 1170.00
View more..